Skip to main content
Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
28.33
-0.10 (-0.33%)
Dec 20, 2024, 4:00 PM EST - Market closed

Immunocore Holdings Revenue

Immunocore Holdings had revenue of $80.25M in the quarter ending September 30, 2024, with 23.74% growth. This brings the company's revenue in the last twelve months to $296.31M, up 25.09% year-over-year. In the year 2023, Immunocore Holdings had annual revenue of $249.43M with 43.05% growth.

Revenue (ttm)
$296.31M
Revenue Growth
+25.09%
P/S Ratio
4.77
Revenue / Employee
$596,201
Employees
497
Market Cap
1.42B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023249.43M75.07M43.05%
Dec 31, 2022174.36M137.88M377.91%
Dec 31, 202136.48M6.37M21.15%
Dec 31, 202030.11M4.45M17.32%
Dec 31, 201925.67M2.02M8.52%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sep 30, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Indivior 1.18B
Novavax 885.19M
AtriCure 447.57M
InMode 423.75M
Phreesia 405.14M
Kiniksa Pharmaceuticals International, 384.10M
Arcus Biosciences 263.00M
Schrödinger 193.35M
Revenue Rankings

IMCR News

More News